{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:15:49Z","timestamp":1793794549940,"version":"4.6.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11648-1","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:19:44Z","timestamp":1759173584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cytomegalovirus infection contributes to acute rejection in solid organ transplant recipients: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Amirreza","family":"Keyvanfar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabnam","family":"Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Falah Tafti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Talebian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Hojabri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepehr","family":"Ramezani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Yasaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setareh","family":"Khorrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Nezami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Ghaedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Yadegarynia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elahe","family":"Eghbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanieh","family":"Najafiarab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"issue":"20","key":"11648_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.21037\/atm.2018.09.68","volume":"6","author":"CK Black","year":"2018","unstructured":"Black CK, Termanini KM, Aguirre O, Hawksworth JS, Sosin M. Solid organ transplantation in the 21(st) century. Ann Transl Med. 2018;6(20):409.","journal-title":"Ann Transl Med"},{"issue":"6","key":"11648_CR2","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1080\/08923973.2021.1966033","volume":"43","author":"H Parlakpinar","year":"2021","unstructured":"Parlakpinar H, Gunata M. Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs. Immunopharmacol Immunotoxicol. 2021;43(6):651\u201365.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"1","key":"11648_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ccc.2018.08.004","volume":"35","author":"A Guenette","year":"2019","unstructured":"Guenette A, Husain S. Infectious complications following solid organ transplantation. Crit Care Clin. 2019;35(1):151\u201368.","journal-title":"Crit Care Clin"},{"issue":"7","key":"11648_CR4","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1093\/cid\/ciz1113","volume":"71","author":"C van Delden","year":"2020","unstructured":"van Delden C, Stampf S, Hirsch HH, Manuel O, Meylan P, Cusini A, et al. Burden and timeline of infectious diseases in the first year after solid organ transplantation in the Swiss transplant cohort study. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2020;71(7):e159\u201369.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"key":"11648_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2023.11802","volume":"36","author":"B Yang","year":"2023","unstructured":"Yang B, Ye Q, Huang C, Ding X. Impact of infection-related immunosuppressant reduction on kidney transplant outcomes: a retrospective study considering the temporal dynamics of immunosuppressive requirements. Transplant Int. 2023;36:11802.","journal-title":"Transplant Int"},{"issue":"6","key":"11648_CR6","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cmi.2018.09.019","volume":"25","author":"A Molina-Ortega","year":"2019","unstructured":"Molina-Ortega A, Mart\u00edn-Gandul C, Mena-Romo JD, Rodr\u00edguez-Hern\u00e1ndez MJ, Su\u00f1er M, Bernal C, et al. Impact of pretransplant CMV-specific T-cell immune response in the control of CMV infection after solid organ transplantation: a prospective cohort study. Clin Microbiol Infect. 2019;25(6):753\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"11648_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2023.11785","volume":"36","author":"CS Walti","year":"2023","unstructured":"Walti CS, Khanna N, Avery RK, Helanter\u00e4 I. New treatment options for refractory\/resistant CMV infection. Transplant Int. 2023;36:11785.","journal-title":"Transplant Int"},{"issue":"4","key":"11648_CR8","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.idc.2019.05.008","volume":"33","author":"R Kumar","year":"2019","unstructured":"Kumar R, Ison MG. Opportunistic infections in transplant patients. Infect Dis Clin N Am. 2019;33(4):1143\u201357.","journal-title":"Infect Dis Clin N Am"},{"key":"11648_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00003","volume":"6","author":"L Couzi","year":"2015","unstructured":"Couzi L, Pitard V, Moreau JF, Merville P, D\u00e9chanet-Merville J. Direct and indirect effects of Cytomegalovirus-induced \u03b3\u03b4 T cells after kidney transplantation. Front Immunol. 2015;6:3.","journal-title":"Front Immunol"},{"issue":"1","key":"11648_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1157\/13114394","volume":"26","author":"MJ P\u00e9rez-Sola","year":"2008","unstructured":"P\u00e9rez-Sola MJ, Cast\u00f3n JJ, Solana R, Rivero A, Torre-Cisneros J. Indirect effects of cytomegalovirus infection in solid organ transplant recipients. Enferm Infecc Microbiol Clin. 2008;26(1):38\u201347.","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"2","key":"11648_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s40121-022-00746-1","volume":"12","author":"CN Kotton","year":"2023","unstructured":"Kotton CN, Kamar N. New insights on CMV management in solid organ transplant patients: prevention, treatment, and management of resistant\/refractory disease. Infect Dis Ther. 2023;12(2):333\u201342.","journal-title":"Infect Dis Ther"},{"issue":"3","key":"11648_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13080","volume":"21","author":"MR Jorgenson","year":"2019","unstructured":"Jorgenson MR, Descourouez JL, Cardinale B, Lyu B, Astor BC, Garg N, et al. Risk of opportunistic infection in kidney transplant recipients with cytomegalovirus infection and associated outcomes. Transplant Infect Dis. 2019;21(3):e13080.","journal-title":"Transplant Infect Dis"},{"issue":"6","key":"11648_CR13","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/MOT.0b013e3282f0d386","volume":"12","author":"AJ Eid","year":"2007","unstructured":"Eid AJ, Razonable RR. Cytomegalovirus disease in solid organ transplant recipients: advances lead to new challenges and opportunities. Curr Opin Organ Transplant. 2007;12(6):610\u20137.","journal-title":"Curr Opin Organ Transplant"},{"issue":"2","key":"11648_CR14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/clpt.2011.90","volume":"90","author":"SA Grim","year":"2011","unstructured":"Grim SA, Clark NM. Management of infectious complications in solid-organ transplant recipients. Clin Pharmacol Ther. 2011;90(2):333\u201342.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"11648_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.idc.2010.02.003","volume":"24","author":"I Helanter\u00e4","year":"2010","unstructured":"Helanter\u00e4 I, Egli A, Koskinen P, Lautenschlager I, Hirsch HH. Viral impact on long-term kidney graft function. Infect Dis Clin North Am. 2010;24(2):339\u201371.","journal-title":"Infect Dis Clin North Am"},{"issue":"9","key":"11648_CR16","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S1473-3099(02)00370-5","volume":"2","author":"F Cainelli","year":"2002","unstructured":"Cainelli F, Vento S. Infections and solid organ transplant rejection: a cause-and-effect relationship? Lancet Infect Dis. 2002;2(9):539\u201349.","journal-title":"Lancet Infect Dis"},{"key":"11648_CR17","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fimmu.2018.00389","volume":"9","author":"NHR Litjens","year":"2018","unstructured":"Litjens NHR, van der Wagen L, Kuball J, Kwekkeboom J. Potential beneficial effects of cytomegalovirus infection after transplantation. Front Immunol. 2018;9:389.","journal-title":"Front Immunol"},{"issue":"4","key":"11648_CR18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264\u20139.","journal-title":"Ann Intern Med"},{"issue":"8","key":"11648_CR19","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/cid\/ciy696","volume":"68","author":"RF Chemaly","year":"2019","unstructured":"Chemaly RF, Chou S, Einsele H, Griffiths P, Avery R, Razonable RR, et al. Definitions of resistant and refractory cytomegalovirus infection and disease in transplant recipients for use in clinical trials. Clin Infect Dis. 2019;68(8):1420\u20136.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"11648_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","volume":"13","author":"Z Munn","year":"2015","unstructured":"Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. International Journal of Evidence-Based Healthcare. 2015;13(3):147\u201353.","journal-title":"International Journal of Evidence-Based Healthcare"},{"issue":"4","key":"11648_CR21","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/S0041-1345(02)02812-9","volume":"34","author":"DR Kuypers","year":"2002","unstructured":"Kuypers DR, Evenepoel P, Maes BD, Coosemans W, Pirenne J, Vanrenterghem YF. Role of immunosuppressive drugs in the development of tissue-invasive cytomegalovirus infection in renal transplant recipients. Transplant Proc. 2002;34(4):1164\u201370.","journal-title":"Transplant Proc"},{"issue":"11","key":"11648_CR22","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1097\/01.TP.0000064709.20841.E1","volume":"75","author":"I Helantera","year":"2003","unstructured":"Helantera I, Koskinen P, Tornroth T, Loginov R, Gronhagen-Riska C, Lautenschlager I. The impact of cytomegalovirus infections and acute rejection episodes on the development of vascular changes in 6-month protocol biopsy specimens of cadaveric kidney allograft recipients. Transplantation. 2003;75(11):1858\u201364.","journal-title":"Transplantation"},{"issue":"12","key":"11648_CR23","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1111\/j.1600-6143.2005.01103.x","volume":"5","author":"C Neurohr","year":"2005","unstructured":"Neurohr C, Huppmann P, Leuchte H, Schwaiblmair M, Bittmann I, Jaeger G, et al. Human herpesvirus 6 in Bronchalveolar lavage fluid after lung transplantation: a risk factor for bronchiolitis obliterans syndrome? Am J Transplant. 2005;5(12):2982\u201391.","journal-title":"Am J Transplant"},{"issue":"10","key":"11648_CR24","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1016\/j.transproceed.2005.11.036","volume":"37","author":"JH Chen","year":"2005","unstructured":"Chen JH, Mao YY, He Q, Wu JY, Lv R. The impact of pretransplant cytomegalovirus infection on acute renal allograft rejection. Transplant Proc. 2005;37(10):4203\u20137.","journal-title":"Transplant Proc"},{"issue":"10","key":"11648_CR25","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1097\/01.tp.0000181161.60638.fa","volume":"80","author":"RR Hachem","year":"2005","unstructured":"Hachem RR, Khalifah AP, Chakinala MM, Yusen RD, Aloush AA, Mohanakumar T, et al. The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation. 2005;80(10):1406\u201313.","journal-title":"Transplantation"},{"issue":"8","key":"11648_CR26","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1111\/j.1600-6143.2005.00953.x","volume":"5","author":"AP Khalifah","year":"2005","unstructured":"Khalifah AP, Hachem RR, Chakinala MM, Yusen RD, Aloush A, Patterson GA, et al. Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome. Am J Transplant. 2005;5(8):2022\u201330.","journal-title":"Am J Transplant"},{"issue":"3","key":"11648_CR27","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/TP.0b013e318192ded5","volume":"87","author":"T Reischig","year":"2009","unstructured":"Reischig T, Jindra P, Hes O, Bouda M, Kormunda S, Treska V. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis. Transplantation. 2009;87(3):436\u201344.","journal-title":"Transplantation"},{"issue":"4","key":"11648_CR28","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1399-0012.2009.00990.x","volume":"23","author":"LD Thomas","year":"2009","unstructured":"Thomas LD, Milstone AP, Miller GG, Loyd JE, Dummer Stephen J. Long-term outcomes of cytomegalovirus infection and disease after lung or heart-lung transplantation with a delayed ganciclovir regimen. Clin Transplant. 2009;23(4):476\u201383.","journal-title":"Clin Transplant"},{"issue":"8","key":"11648_CR29","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1016\/j.transproceed.2009.07.068","volume":"41","author":"M Zakliczynski","year":"2009","unstructured":"Zakliczynski M, Krynicka-Mazurek A, Konecka-Mrowka D, Nozynski J, Zegle\u0144 S, Przybylski R, et al. Cytomegalovirus infection does not accelerate microvasculopathy development in heart transplant recipients. Transpl Proc. 2009;41(8):3219\u201321.","journal-title":"Transpl Proc"},{"issue":"6","key":"11648_CR30","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.intimp.2008.09.013","volume":"9","author":"E Sarmiento","year":"2009","unstructured":"Sarmiento E, Lanio N, Gallego A, Rodriguez-Molina J, Navarro J, Fernandez-Ya\u00f1ez J, et al. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation. Int Immunopharmacol. 2009;9(6):649\u201352.","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"11648_CR31","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1016\/j.transproceed.2012.07.027","volume":"44","author":"AC Guardia-Silva","year":"2012","unstructured":"Guardia-Silva AC, Stucchi RS, Sampaio AM, Milan A, Costa SC, Boin IF. Detection of cytomegalovirus and human herpesvirus-6 DNA in liver biopsy specimens and their correlation with rejection after liver transplantation. Transplant Proc. 2012;44(8):2441\u20134.","journal-title":"Transplant Proc"},{"issue":"2","key":"11648_CR32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/tid.12036","volume":"15","author":"SP Hammond","year":"2013","unstructured":"Hammond SP, Martin ST, Roberts K, Gabardi S, Fuhlbrigge AL, Camp PC, et al. Cytomegalovirus disease in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis. Transplant infectious dis. 2013;15(2):163\u201370.","journal-title":"Transplant infectious dis"},{"key":"11648_CR33","doi-asserted-by":"crossref","unstructured":"Bal Z, Uyar ME, Tutal E, Erdogan E, Colak T, Sezer S et al. Cytomegalovirus infection in renal transplant recipients: one center\u2019s experience. Transplantation proceedings. 2013;45(10):3520-3.","DOI":"10.1016\/j.transproceed.2013.08.098"},{"issue":"1","key":"11648_CR34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/ctr.12288","volume":"28","author":"YV Smedbr\u00e5ten","year":"2014","unstructured":"Smedbr\u00e5ten YV, Sagedal S, Leivestad T, Mj\u00f8en G, Osnes K, Rollag H, et al. The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival. Clin Transplant. 2014;28(1):120\u20136.","journal-title":"Clin Transplant"},{"key":"11648_CR35","doi-asserted-by":"publisher","first-page":"358","DOI":"10.12659\/AOT.883977","volume":"18","author":"GI Snell","year":"2013","unstructured":"Snell GI, Levvey BJ, Paraskeva M, Oto T, Bailey M, Walker R, et al. The influence of clinical donor factors on acute rejection among lung and kidney recipients from the same multi-organ donor. Ann Transplant. 2013;18:358\u201367.","journal-title":"Ann Transplant"},{"issue":"3","key":"11648_CR36","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/tid.12227","volume":"16","author":"YM Lee","year":"2014","unstructured":"Lee YM, Kim YH, Han DJ, Park SK, Park JS, Sung H, et al. Cytomegalovirus infection after acute rejection therapy in seropositive kidney transplant recipients. Transpl Infect Disease: Official J Transplantation Soc. 2014;16(3):397\u2013402.","journal-title":"Transpl Infect Disease: Official J Transplantation Soc"},{"issue":"6","key":"11648_CR37","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3851\/IMP3129","volume":"22","author":"T Reischig","year":"2017","unstructured":"Reischig T, Kacer M, Hruba P, Jindra P, Hes O, Lysak D, et al. The impact of viral load and time to onset of cytomegalovirus replication on long-term graft survival after kidney transplantation. Antivir Ther. 2017;22(6):503\u201313.","journal-title":"Antivir Ther"},{"key":"11648_CR38","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.16321.1","volume":"7","author":"MN Chitasombat","year":"2018","unstructured":"Chitasombat MN, Watcharananan SP. Burden of cytomegalovirus reactivation post kidney transplant with antithymocyte Globulin use in Thailand: a retrospective cohort study. F1000Res. 2018;7:1568.","journal-title":"F1000Res"},{"issue":"4","key":"11648_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12905","volume":"20","author":"SK Yadav","year":"2018","unstructured":"Yadav SK, Saigal S, Choudhary NS, Saha S, Sah JK, Saraf N, et al. Cytomegalovirus infection in living donor liver transplant recipients significantly impacts the early post-transplant outcome: a single center experience. Transplant Infect Dis. 2018;20(4):e12905.","journal-title":"Transplant Infect Dis"},{"issue":"6","key":"11648_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13106","volume":"21","author":"C Felipe","year":"2019","unstructured":"Felipe C, Ferreira AN, de Paula M, Viana L, Cristelli M, Medina Pestana J, et al. Incidence and risk factors associated with cytomegalovirus infection after the treatment of acute rejection during the first year in kidney transplant recipients receiving preemptive therapy. Transplant Infect Dis. 2019;21(6):e13106.","journal-title":"Transplant Infect Dis"},{"issue":"3","key":"11648_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13069","volume":"21","author":"A Chang","year":"2019","unstructured":"Chang A, Musk M, Lavender M, Wrobel J, Yaw MC, Lawrence S, et al. Cytomegalovirus viremia in lung transplantation during and after prophylaxis. Transplant Infectious Dis. 2019;21(3):e13069.","journal-title":"Transplant Infectious Dis"},{"key":"11648_CR42","doi-asserted-by":"crossref","unstructured":"Bischof N, Wehmeier C, Dickenmann M, Hirt-Minkowski P, Amico P, Steiger J, et al. Revisiting cytomegalovirus serostatus and replication as risk factors for inferior long-term outcomes in the current era of renal transplantation. Nephrol Dial Transplant. 2020;35(2):346\u201356.","DOI":"10.1093\/ndt\/gfz268"},{"issue":"9","key":"11648_CR43","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/tri.13667","volume":"33","author":"R Singh","year":"2020","unstructured":"Singh R, Peters-Sengers H, Remmerswaal EBM, Yapici U, van der Pant K, van der Weerd NC, et al. Clinical consequences of primary CMV infection after renal transplantation: a case-control study. Transpl International: Official J Eur Soc Organ Transplantation. 2020;33(9):1116\u201327.","journal-title":"Transpl International: Official J Eur Soc Organ Transplantation"},{"issue":"6","key":"11648_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14285","volume":"35","author":"M Rahimishahmirzadi","year":"2021","unstructured":"Rahimishahmirzadi M, Jevnikar AM, House AA, Luke PP, Humar A, Silverman MS, et al. Late-onset allograft rejection, cytomegalovirus infection, and renal allograft loss: is anti-CMV prophylaxis required following late-onset allograft rejection? Clin Transplant. 2021;35(6):e14285.","journal-title":"Clin Transplant"},{"key":"11648_CR45","doi-asserted-by":"publisher","first-page":"1190794","DOI":"10.3389\/fcimb.2023.1190794","volume":"13","author":"S Ishikawa","year":"2023","unstructured":"Ishikawa S, Tasaki M, Saito K, Nakagawa Y, Ikeda M, Takahashi K, et al. Long-term CMV monitoring and chronic rejection in renal transplant recipients. Front Cell Infect Microbiol. 2023;13:1190794.","journal-title":"Front Cell Infect Microbiol"},{"key":"11648_CR46","doi-asserted-by":"publisher","first-page":"1171197","DOI":"10.3389\/fimmu.2023.1171197","volume":"14","author":"A Saldan","year":"2023","unstructured":"Saldan A, Mengoli C, Sgarabotto D, Fedrigo M, Angelini A, Feltrin G, et al. Human cytomegalovirus and Epstein-Barr virus infections occurring early after transplantation are risk factors for antibody-mediated rejection in heart transplant recipients. Front Immunol. 2023;14:1171197.","journal-title":"Front Immunol"},{"issue":"5","key":"11648_CR47","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1177\/10600280221120059","volume":"57","author":"X Zhang","year":"2023","unstructured":"Zhang X, Lichvar A, Chan C, Choi D. Evaluating the incidence and risk factors for acute cellular rejection in a steroid sparing liver transplant center. Ann Pharmacother. 2023;57(5):553\u20139.","journal-title":"Ann Pharmacother"},{"issue":"12","key":"11648_CR48","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1111\/ajt.13486","volume":"15","author":"C Martin-Gandul","year":"2015","unstructured":"Martin-Gandul C, Mueller NJ, Pascual M, Manuel O. The impact of infection on chronic allograft dysfunction and allograft survival after solid organ transplantation. Am J Transplant. 2015;15(12):3024\u201340.","journal-title":"Am J Transplant"},{"key":"11648_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9082352","author":"C Engelmann","year":"2020","unstructured":"Engelmann C, Sterneck M, Weiss KH, Templin S, Zopf S, Denk G, et al. Prevention and management of CMV infections after liver transplantation: current practice in German transplant centers. J Clin Med. 2020. https:\/\/doi.org\/10.3390\/jcm9082352.","journal-title":"J Clin Med"},{"issue":"6","key":"11648_CR50","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/TP.0000000000002191","volume":"102","author":"CN Kotton","year":"2018","unstructured":"Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L, et al. The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2018;102(6):900\u201331.","journal-title":"Transplantation"},{"key":"11648_CR51","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12773","author":"D Navarro","year":"2017","unstructured":"Navarro D, San-Juan R, Manuel O, Gim\u00e9nez E, Fern\u00e1ndez-Ruiz M, Hirsch HH, et al. Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: an ESGICH survey. Transplant Infect Dis. 2017. https:\/\/doi.org\/10.1111\/tid.12773.","journal-title":"Transplant Infect Dis"},{"issue":"1","key":"11648_CR52","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3947\/ic.2024.0016","volume":"56","author":"K Huh","year":"2024","unstructured":"Huh K, Lee SO, Kim J, Lee SJ, Choe PG, Kang JM, et al. Prevention of cytomegalovirus infection in solid organ transplant recipients: guidelines by the Korean society of infectious diseases and the Korean society for transplantation. Infect Chemother. 2024;56(1):101\u201321.","journal-title":"Infect Chemother"},{"issue":"1","key":"11648_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2405","volume":"33","author":"P Moseley","year":"2023","unstructured":"Moseley P, Klenerman P, Kadambari S. Indirect effects of cytomegalovirus infection: implications for vaccine development. Rev Med Virol. 2023;33(1):e2405.","journal-title":"Rev Med Virol"},{"issue":"9","key":"11648_CR54","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/TP.0000000000000160","volume":"98","author":"M Stern","year":"2014","unstructured":"Stern M, Hirsch H, Cusini A, van Delden C, Manuel O, Meylan P, et al. Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment. Transplantation. 2014;98(9):1013\u20138.","journal-title":"Transplantation"},{"issue":"9","key":"11648_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13512","volume":"33","author":"RR Razonable","year":"2019","unstructured":"Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients-guidelines of the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019;33(9):e13512.","journal-title":"Clin Transplant"},{"key":"11648_CR56","doi-asserted-by":"publisher","first-page":"645718","DOI":"10.3389\/fimmu.2021.645718","volume":"12","author":"MML Kho","year":"2021","unstructured":"Kho MML, Roest S, Bov\u00e9e DM, Metselaar HJ, Hoek RAS, van der Eijk AA, et al. Herpes zoster in solid organ transplantation: incidence and risk factors. Front Immunol. 2021;12:645718.","journal-title":"Front Immunol"},{"issue":"3","key":"11648_CR57","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/TP.0000000000004297","volume":"107","author":"LE Higdon","year":"2023","unstructured":"Higdon LE, Tan JC, Maltzman JS. Infection, rejection, and the connection. Transplantation. 2023;107(3):584\u201395.","journal-title":"Transplantation"},{"key":"11648_CR58","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1186\/s12879-015-1321-1","volume":"15","author":"I Johansson","year":"2015","unstructured":"Johansson I, Andersson R, Friman V, Selimovic N, Hanzen L, Nasic S, et al. Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients. BMC Infect Dis. 2015;15:582.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"11648_CR59","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1097\/TP.0000000000003015","volume":"104","author":"D Klimczak-Tomaniak","year":"2020","unstructured":"Klimczak-Tomaniak D, Roest S, Brugts JJ, Caliskan K, Kardys I, Zijlstra F, et al. The association between cytomegalovirus infection and cardiac allograft vasculopathy in the era of antiviral valganciclovir prophylaxis. Transplantation. 2020;104(7):1508\u201318.","journal-title":"Transplantation"},{"issue":"8","key":"11648_CR60","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.healun.2015.03.015","volume":"34","author":"JF Delgado","year":"2015","unstructured":"Delgado JF, Reyne AG, de Dios S, L\u00f3pez-Medrano F, Jurado A, Juan RS, et al. Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation. J Heart Lung Transplant. 2015;34(8):1112\u20139.","journal-title":"J Heart Lung Transplant"},{"key":"11648_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd11030095","author":"MA Kamel","year":"2024","unstructured":"Kamel MA, Scalia IG, Badr AT, Baba Ali N, Farina JM, Pereyra M, et al. Cardiac allograft vasculopathy: challenges and advances in invasive and non-invasive diagnostic modalities. J Cardiovasc Dev Dis. 2024. https:\/\/doi.org\/10.3390\/jcdd11030095.","journal-title":"J Cardiovasc Dev Dis"},{"issue":"1s","key":"11648_CR62","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/j.chest.2020.03.014","volume":"158","author":"X Wang","year":"2020","unstructured":"Wang X, Kattan MW. Cohort studies: design, analysis, and reporting. Chest. 2020;158(1s):S72-8.","journal-title":"Chest"},{"key":"11648_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2022.10332","author":"PA Grossi","year":"2022","unstructured":"Grossi PA, Kamar N, Saliba F, Baldanti F, Aguado JM, Gottlieb J, et al. Cytomegalovirus management in solid organ transplant recipients: a pre-COVID-19 survey from the working group of the European society for organ transplantation. Transplant Int. 2022. https:\/\/doi.org\/10.3389\/ti.2022.10332.","journal-title":"Transplant Int"},{"key":"11648_CR64","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-024-02441-4","author":"N Reiss-Gindi","year":"2024","unstructured":"Reiss-Gindi N, Hoffman T, Ruderman T, Atamna A, Margalit I, Yahav D. Prophylactic vs preemptive strategy for the prevention of CMV disease in solid organ transplant recipients: systematic review and meta-analysis of randomized controlled trials. Infection. 2024. https:\/\/doi.org\/10.1007\/s15010-024-02441-4.","journal-title":"Infection"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11648-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11648-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11648-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T01:03:14Z","timestamp":1759194194000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11648-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11648"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11648-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"29 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1205"}}